IMNN
NASD Imunon, Inc.$1.02 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.02, $0.03 below the day’s high of $1.05
- YTD change
- -73.23%
- vs 20-day SMA
- -18.48%
- vs 200-day SMA
- -57.25%
Price ranges
Price & Performance
-2.08 (-67.10%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 97.9% away from all-time highs of $47.61
- IMNN is down 73% since the beginning of the year
- IMNN is down 80% over the past 12 months
- IMNN is down 26% over the past 1 month
- 3% of all IMNN investors are betting against IMNN
IMNN reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -80.0%.
- Previous minute
- +$0.00
- Last hour
- -$0.07
- Last 5 days
- -4.67%
- vs 8-day SMA
- -5.66%
No alerts for IMNN in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.